Omnibus III / 03-105 - efficacy, immunogenicity and safety of norovirus bivalent VLP vaccine in adults [study designation nor-211] exempt
Ended Awarded Last action
- Contract number
- 0015
- Awardee
-
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. UEI UYLKBRENAPG5
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $4,267,682
Award facts
- Opportunity
-
- W911QY10R0027 Solicitation number
- PRESOLICITATION NOTIFICATION UPDATE* This is an update from the previous Presolicitation Notice for W911QY-10-R-0027 for the NHRC Omnibus III ID/IQ. The Government intends to release the Final Request for Proposal within 45 days. Award Notice · Posted Jun 3, 2010
- This effort includes: conducting extramural medical research or intramural (on-site) medical research performed by contractors; rapidly developing prototype infrastructure augmentations necessary to conduct such research. Award Notice · Posted Jan 8, 2010
- Contract value 74% obligated
- $5,783,938.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92106, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$773,527 | |
| Supplemental Agreement for work within scope | $641,000 | |
| Funding Only Action | $250,000 | |
| Other Administrative Action | $0 | |
| Change Order | $675,000 | |
| Change Order | $0 | |
| Funding Only Action | $772,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,000,000 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Funding Only Action | $208,059 | |
| Funding Only Action | $1,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $495,150 |
Show all 16
About this award
This is a Cost Plus Fixed Fee delivery order awarded by the Bureau of Medicine and Surgery (Navy Medicine) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) under the Navy Medicine R&D Support Omnibus III contract vehicle. The $5,783,938.31 contract is for a study to evaluate the efficacy, immunogenicity, and safety of a norovirus bivalent virus-like particle (VLP) vaccine in adults, with a period of performance ending on October 31, 2018. HJF is a non-profit organization that frequently acts as a prime contractor for the Department of Defense (DoD), Department of Veterans Affairs (VA), and other federal agencies, providing a wide range of medical research, training, and support services. This award is not designated as a set-aside.
Quick answers
Who was awarded contract 0015?
0015 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on December 2, 2015.
How much is contract 0015 worth?
The government has obligated $4,267,682 on 0015. Its current value, with exercised options, is $5,783,938.
Is contract 0015 an order under another contract?
Yes. 0015 is a delivery order under W911QY11D0053, an indefinite delivery contract, on Navy Medicine R&D Support Omnibus III.
Was contract 0015 competed?
The extent of competition for 0015 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award